1. Thurman DJ. The epidemiology of traumatic brain injury in childrenThurman DJ. The epidemiology of traumatic brain injury in childrenand youths: a review of research since 1990. Journal of child neurology.2016;31(1):20-27.
2. Öztan MO, Bolova G, Sayan A, et al. Comparison of Syrian andTurkish patients with trauma who hospitalized in the pediatric surgerydepartment. Cocuk Acil ve Yogun Bakım. 2019;6(1):30.
3. Chang D. Comparison of crash fatalities by sex and age group. NationalCenter for Statistics and Analysis. 2008;July:1-5.
4. Marin JR, Weaver MD, Barnato AE, Yabes JG, Yealy DM, Roberts MS.Variation in emergency department head computed tomography use forpediatric head trauma. Academic Emergency Medicine. 2014;21(9):987-995.
5. Mihindu E, Bhullar I, Tepas J, Kerwin A. Computed tomography ofthe head in children with mild traumatic brain injury. The Americansurgeon. 2014;80(9):841-843.
6. Cassidy JD, Carroll L, Peloso P, et al. Incidence, risk factors andprevention of mild traumatic brain injury: results of the WHOcollaborating centre task force on mild traumatic brain injury. Journalof rehabilitation medicine. 2004;36(0):28-60.
7. Brenner DJ. Estimating cancer risks from pediatric CT: going from thequalitative to the quantitative. Pediatric radiology. 2002;32(4):228-231.
8. Sheppard JP, Nguyen T, Alkhalid Y, Beckett JS, Salamon N, Yang I.Risk of brain tumor induction from pediatric head CT procedures:a systematic literature review. Brain tumor research and treatment.2018;6(1):1-7.
9. Ferrari A, Coccia C, Sternieri E. Past, present, and future prospects ofmedication-overuse headache classification. Headache: The Journal ofHead and Face Pain. 2008;48(7):1096-1102.
10. Shaw GJ, Jauch EC, Zemlan FP. Serum cleaved tau protein levels andclinical outcome in adult patients with closed head injury. Annals of Emergency Medicine. 2002;39(3):254-257.
11. Gao J, Zheng Z. Development of prognostic models for patients withtraumatic brain injury: a systematic review. International journal ofclinical and experimental medicine. 2015;8(11):19881.
12. Ilginel MT, Lafli TD, Güneş Y. Travmatik beyin hasarındabiyobelirteçler. Anestezi Dergisi. 2018;26(3):105-119.
13. Sirois-Gagnon D, Chamberland A, Perron S, Brisson D, Gaudet D,Laprise C. Association of common polymorphisms in the fractalkinereceptor (CX3CR1) with obesity. Obesity. 2011;19(1):222-227.
14. Sharma R, Laskowitz DT. Biomarkers in traumatic brain injury.Current neurology and neuroscience reports. 2012;12(5):560-569.
15. Thelin EP, Nelson DW, Bellander B-M. A review of the clinical utility ofserum S100B protein levels in the assessment of traumatic brain injury.Acta neurochirurgica. 2017;159(2):209-225.
16. Oris C, Pereira B, Durif J, et al. The biomarker S100B and mildtraumatic brain injury: a meta-analysis. Pediatrics. 2018;141(6).
17. Piazza O, Storti M, Cotena S, et al. S100B is not a reliable prognosticindex in paediatric TBI. Pediatric neurosurgery. 2007;43(4):258-264.
18. Filippidis AS, Papadopoulos DC, Kapsalaki EZ, Fountas KN. Role ofthe S100B serum biomarker in the treatment of children suffering frommild traumatic brain injury. Neurosurgical focus. 2010;29(5):E2.
19. Zanier ER, Marchesi F, Ortolano F, et al. Fractalkine receptordeficiency is associated with early protection but late worsening ofoutcome following brain trauma in mice. Journal of neurotrauma.2016;33(11):1060-1072.
20. Tweedie D, Karnati HK, Mullins R, et al. Time-dependent cytokineand chemokine changes in mouse cerebral cortex following a mildtraumatic brain injury. Elife. 2020;9:e55827.